Atlas Trials

The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction

Clinical trial NCT02554253 · COMPLETED

Trial details

NCT number
NCT02554253
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive DisordersDeliriumAcute Kidney Injury
Start date
2015-09-01
Primary completion
2020-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.